articleNature MedicineMar 3, 2013Closed access

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

GLGenmin LuFDFrancis DeGuzmanSJStanley J. HollenbachMJMark J. KarbarzKAKeith Abe

Portola Pharmaceuticals (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

692
total citations
FWCI
78.96
Percentile
100%
References
35
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Antidote
  • Rivaroxaban
  • Pharmacology
  • Coagulation
  • Factor IX
  • Antithrombin
  • Medicine
  • Chemistry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.